Literature DB >> 10618268

Serum cytokine responses during acute human granulocytic ehrlichiosis.

J S Dumler1, E R Trigiani, J S Bakken, M E Aguero-Rosenfeld, G P Wormser.   

Abstract

Human granulocytic ehrlichiosis (HGE) is caused by obligate intracellular bacteria in the Ehrlichia phagocytophila group. The disease ranges from subclinical to fatal. We speculated that cell-mediated immunity would be important for recovery from and potentially in the clinical manifestations of HGE; thus, serum tumor necrosis factor alpha (TNF-alpha), interleukin 1beta (IL-1beta), gamma interferon (IFN-gamma), IL-10, and IL-4 concentrations were studied. IFN-gamma (1,035 +/- 235 pg/ml [mean +/- standard error of the mean]) and IL-10 (118 +/- 46 pg/ml) concentrations were elevated in acute-phase sera versus convalescent sera and normal subjects (P </= 0.013 and P </= 0.018, respectively). TNF-alpha, IL-1beta, and IL-4 levels were not elevated. Cytokine levels in severely and mildly affected patients were not different. HGE leads to induction of IFN-gamma-dominated cell-mediated immunity associated with clinical manifestations, recovery from infection, or both.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618268      PMCID: PMC95813          DOI: 10.1128/CDLI.7.1.6-8.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  Cytokines and infectious diseases.

Authors:  M Fresno; M Kopf; L Rivas
Journal:  Immunol Today       Date:  1997-02

2.  High levels of interferon-gamma in boutonneuse fever.

Authors:  S Mansueto; G Vitale; E Cillari; C Mocciaro; G Gambino; E Piccione; S Buscemi; G Rotondo
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

3.  The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines.

Authors:  M B Klein; S Hu; C C Chao; J L Goodman
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

4.  Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model.

Authors:  M E Martin; J E Bunnell; J S Dumler
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

5.  Serum Levels of Interferon-gamma, Cytotoxic Factor and Soluble Interleukin-2 Receptor in Childhood Hemophagocytic Syndromes.

Authors:  S Imashuku; S Ikushima; N Esumi; S Todo; M Saito
Journal:  Leuk Lymphoma       Date:  1991

6.  Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease.

Authors:  H M Feng; V L Popov; D H Walker
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  L-arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon.

Authors:  J Park; Y Rikihisa
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

8.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

9.  Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin.

Authors:  R E Barnewall; Y Rikihisa
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.

Authors:  A Keane-Myers; S P Nickell
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

View more
  23 in total

1.  Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum.

Authors:  R S Davies; J E Madigan; E Hodzic; D L Borjesson; J S Dumler
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

Review 2.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  The role of CD8 T lymphocytes in rickettsial infections.

Authors:  David H Walker; J Stephen Dumler
Journal:  Semin Immunopathol       Date:  2015-04-01       Impact factor: 9.623

4.  Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Yasunori Ogura; Joao H F Pedra; Koichi S Kobayashi; Richard A Flavell; Erol Fikrig
Journal:  FEMS Immunol Med Microbiol       Date:  2012-07-23

5.  Anaplasma phagocytophilum, interferon gamma production and Stat1 signaling.

Authors:  Kyoung-Seong Choi; J Stephen Dumler
Journal:  Microbiol Immunol       Date:  2013-03       Impact factor: 1.955

6.  Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection.

Authors:  Kyoung-Seong Choi; Tonya Webb; Mathias Oelke; Diana G Scorpio; J Stephen Dumler
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  First case of human "Candidatus Neoehrlichia mikurensis" infection in a febrile patient with chronic lymphocytic leukemia.

Authors:  Christina Welinder-Olsson; Eva Kjellin; Krista Vaht; Stefan Jacobsson; Christine Wennerås
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

8.  Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila.

Authors:  Hyung-Yong Kim; Jason Mott; Ning Zhi; Tomoko Tajima; Yasuko Rikihisa
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 9.  Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient.

Authors:  Nasia Safdar; Robert B Love; Dennis G Maki
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum.

Authors:  Uta Bussmeyer; Arup Sarkar; Kirsten Broszat; Tanja Lüdemann; Sonja Möller; Ger van Zandbergen; Christian Bogdan; Martina Behnen; J Stephen Dumler; Friederike D von Loewenich; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.